BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 35127905)

  • 1. Dynamic monitoring of carcinoembryonic antigen, CA19-9 and inflammation-based indices in patients with advanced colorectal cancer undergoing chemotherapy.
    Manojlovic N; Savic G; Nikolic B; Rancic N
    World J Clin Cases; 2022 Jan; 10(3):899-918. PubMed ID: 35127905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Prognostic Markers {CEA, Ca19.9, Neutrophil To Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR)} With Progression Free Survival (PFS) in Advanced/Metastatic Gallbladder Carcinoma.
    Naik MD; Kataria SP; Kumar G; Singh R
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
    He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
    Front Oncol; 2022; 12():829689. PubMed ID: 35296020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Diagnostic Value Of Combining Inflammatory Cell Ratios With Carcinoembryonic Antigen For Colorectal Cancer.
    Li X; Guo D; Chu L; Huang Y; Zhang F; Li W; Chen J
    Cancer Manag Res; 2019; 11():9631-9640. PubMed ID: 32009818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can carcinoembryonic antigen replace computed tomography in response evaluation of metastatic colorectal cancer?
    Hermunen K; Lantto E; Poussa T; Haglund C; Österlund P
    Acta Oncol; 2018 Jun; 57(6):750-758. PubMed ID: 29388498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in the neutrophil-to-lymphocyte ratio during chemotherapy may predict prognosis in patients with advanced or metastatic colorectal cancer.
    Nemoto T; Endo S; Isohata N; Takayanagi D; Nemoto D; Aizawa M; Utano K; Togashi K
    Mol Clin Oncol; 2021 May; 14(5):107. PubMed ID: 33815795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of related factors of prognosis after surgical treatment of patients with non-metastatic colorectal cancer and construction of a normagram prediction model].
    Liu SX; Zhang L; Shi YK; Han XH
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):167-172. PubMed ID: 35184461
    [No Abstract]   [Full Text] [Related]  

  • 8. The values of systemic immune-inflammation index and neutrophil-lymphocyte ratio in predicting testicular germ cell tumors: A retrospective clinical study.
    Wang S; Yang X; Yu Z; Du P; Cao Y; Ji Y; Ma J; Yang Y
    Front Oncol; 2022; 12():893877. PubMed ID: 36185298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC).
    Sefrioui D; Beaussire L; Gillibert A; Blanchard F; Toure E; Bazille C; Perdrix A; Ziegler F; Gangloff A; Hassine M; Elie C; Bignon AL; Parzy A; Gomez P; Thill C; Clatot F; Sabourin JC; Frebourg T; Benichou J; Bouhier-Leporrier K; Gallais MP; Sarafan-Vasseur N; Michel P; Di Fiore F
    Br J Cancer; 2021 Aug; 125(5):725-733. PubMed ID: 34112948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy.
    Shin K; Jung EK; Park SJ; Jeong S; Kim IH; Lee MA
    World J Gastrointest Oncol; 2021 Aug; 13(8):915-928. PubMed ID: 34457195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of changes in systemic inflammatory markers and carcinoembryonic antigen levels in predicting metastatic colorectal cancer prognosis and chemotherapy response.
    Kim IH; Lee JE; Yang JH; Jeong JW; Ro S; Lee MA
    Asia Pac J Clin Oncol; 2018 Jun; 14(3):239-246. PubMed ID: 29044941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inflammation score predicts the prognosis of gastric cancer patients undergoing Da Vinci robot surgery.
    Chen X; Zhang Y; Liu Z; Song J; Li J
    J Robot Surg; 2024 Mar; 18(1):131. PubMed ID: 38498240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compare the Diagnostic and Prognostic Value of MLR, NLR and PLR in CRC Patients.
    Kang Y; Zhu X; Lin Z; Zeng M; Shi P; Cao Y; Chen F
    Clin Lab; 2021 Sep; 67(9):. PubMed ID: 34542964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of NLR, FIB, CEA and CA19-9 in colorectal cancer].
    Qian X; Wang H; Ren Z; Jin F; Pan SY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Apr; 55(4):499-505. PubMed ID: 33858062
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients.
    Tang X; Cao Y; Liu J; Wang S; Yang Y; Du P
    Front Mol Biosci; 2020; 7():575483. PubMed ID: 33251247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation-based markers can predict the prognosis of geriatric patients with metastatic colorectal cancer receiving first-line chemotherapy.
    Guo G; Chen X; Cai X; Chen Y; Wang H; Fan L; Bai L; Qiu H; Zhang B
    Transl Cancer Res; 2019 Aug; 8(4):1137-1147. PubMed ID: 35116856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab.
    Passardi A; Azzali I; Bittoni A; Marisi G; Rebuzzi F; Molinari C; Bartolini G; Matteucci L; Sullo FG; Debonis SA; Gallio C; Monti M; Valgiusti M; Muratore M; Rapposelli IG; Ulivi P; Frassineti GL
    Ther Adv Med Oncol; 2023; 15():17588359231212184. PubMed ID: 38107830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of Carcinoembryonic Antigen Combined with Multi-Inflammatory Cell Ratios in Colorectal Cancer.
    Liu XC; Dai YL; Huang F; Zhong ZJ; Liu XF
    Dis Markers; 2022; 2022():4889616. PubMed ID: 36061352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.